This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Everitt, J. I. Articles by Walker, C. Search for Related Content PubMed PubMed Citation Articles by Everitt, J. I. Articles by Walker, C.

American Journal of Pathology, Vol 146, 1556-1567, Copyright © 1995 by American Society for Investigative Pathology

REGULAR ARTICLES

Rodent model of reproductive tract leiomyomata. Clinical and pathological features

JI Everitt, DC Wolf, SR Howe, TL Goldsworthy and C Walker
Department of Experimental Pathology and Toxicology, Chemical Industry Institute of Toxicology, Research Triangle Park, North Carolina 27709, USA.

Mesenchymal tumors of the lower reproductive tract of women are poorly understood at the molecular level as a result in part of the lack of relevant animal models. The present study describes a novel model of gynecological smooth muscle tumors in which these neoplasms arise in Eker rats as part of a familial cancer syndrome. The tumors develop as a result of a germline mutation in the tuberous sclerosis 2 (TSC2) gene, and predisposition to tumor development is inherited in an autosomal dominant fashion. Uterine and/or cervical tumors arise spontaneously as single or multicentric neoplasms and increase in incidence with increasing age. The tumors were classified into three phenotypic variants of leiomyoma/leiomyosarcoma and into stromal cervicovaginal tumors on the basis of cytological and histological features and immunostaining patterns for smooth muscle actin and desmin. Tumors histologically identical to the typical human myometrial leiomyoma arose, as did a subset of atypical leiomyomas having an epithelioid phenotype. Eker rats were found to develop both benign and malignant smooth muscle tumors. The high spontaneous incidence of smooth muscle tumors of uterus and cervix in this rodent model provides a unique opportunity to study the molecular mechanisms underlying the development of these clinically important gynecological neoplasms.

This article has been cited by other articles:

				M.H. Hassan, N. Khatoon, D.T. Curiel, F.M. Hamada, H.M. Arafa, and A. Al-Hendy Toward gene therapy of uterine fibroids: targeting modified adenovirus to human leiomyoma cells Hum. Reprod., March 1, 2008; 23(3): 514 - 524. [Abstract] [Full Text] [PDF]

				E. Billon-Denis, Z. Tanfin, and P. Robin Role of lysophosphatidic acid in the regulation of uterine leiomyoma cell proliferation by phospholipase D and autotaxin J. Lipid Res., February 1, 2008; 49(2): 295 - 307. [Abstract] [Full Text] [PDF]

				A. Isobe, T. Takeda, M. Sakata, A. Miyake, T. Yamamoto, R. Minekawa, F. Nishimoto, Y. Oskamoto, C. L. Walker, and T. Kimura Dual repressive effect of angiotensin II-type 1 receptor blocker telmisartan on angiotensin II-induced and estradiol-induced uterine leiomyoma cell proliferation Hum. Reprod., February 1, 2008; 23(2): 440 - 446. [Abstract] [Full Text] [PDF]

				N. J. Laping, J. I. Everitt, K. S. Frazier, M. Burgert, M. J. Portis, C. Cadacio, L. I. Gold, and C. L. Walker Tumor-Specific Efficacy of Transforming Growth Factor-{beta}RI Inhibition in Eker Rats Clin. Cancer Res., May 15, 2007; 13(10): 3087 - 3099. [Abstract] [Full Text] [PDF]

				A. Al-Hendy and S. Salama Gene therapy and uterine leiomyoma: a review Hum. Reprod. Update, July 1, 2006; 12(4): 385 - 400. [Abstract] [Full Text] [PDF]

				E. A. Goncharova, D. A. Goncharov, P. N. Lim, D. Noonan, and V. P. Krymskaya Modulation of Cell Migration and Invasiveness by Tumor Suppressor TSC2 in Lymphangioleiomyomatosis Am. J. Respir. Cell Mol. Biol., April 1, 2006; 34(4): 473 - 480. [Abstract] [Full Text] [PDF]

				J. D. Cook, B. J. Davis, S.-L. Cai, J. C. Barrett, C. J. Conti, and C. L. Walker Interaction between genetic susceptibility and early-life environmental exposure determines tumor-suppressor-gene penetrance PNAS, June 14, 2005; 102(24): 8644 - 8649. [Abstract] [Full Text] [PDF]

				K. Mozzachio, K. Linder, and D. Dixon Uterine Smooth Muscle Tumors in Potbellied Pigs (Sus scrofa) Resemble Human Fibroids: A Potential Animal Model Toxicol Pathol, June 1, 2004; 32(4): 402 - 407. [Abstract] [PDF]

				K. Politi, M. Szabolcs, P. Fisher, A. Kljuic, T. Ludwig, and A. Efstratiadis A Mouse Model of Uterine Leiomyosarcoma Am. J. Pathol., January 1, 2004; 164(1): 325 - 336. [Abstract] [Full Text] [PDF]

				T. L. Cornwell, E. K. Ceaser, J. Li, K. L. Marrs, V. M. Darley-Usmar, and R. P. Patel S-nitrosothiols inhibit uterine smooth muscle cell proliferation independent of metabolism to NO and cGMP formation Am J Physiol Cell Physiol, June 1, 2003; 284(6): C1516 - C1524. [Abstract] [Full Text] [PDF]

				K. D. Houston, J. A. Copland, R. R. Broaddus, M. M. Gottardis, S. M. Fischer, and C. L. Walker Inhibition of Proliferation and Estrogen Receptor Signaling by Peroxisome Proliferator-activated Receptor {gamma} Ligands in Uterine Leiomyoma Cancer Res., March 15, 2003; 63(6): 1221 - 1227. [Abstract] [Full Text] [PDF]

				S. Cai, J. I. Everitt, H. Kugo, J. Cook, E. Kleymenova, and C. L. Walker Polycystic Kidney Disease as a Result of Loss of the Tuberous Sclerosis 2 Tumor Suppressor Gene During Development Am. J. Pathol., February 1, 2003; 162(2): 457 - 468. [Abstract] [Full Text] [PDF]

				J. S. Munday and N. L. Stedman Uterine Leiomyomas in Two Vietnamese Pot-bellied Pigs (Sus scrofa) Vet. Pathol., September 1, 2002; 39(5): 580 - 583. [Abstract] [Full Text] [PDF]

				D. S. Hunter, M. Klotzbucher, H. Kugoh, S.-L. Cai, J. P. Mullen, G. Manfioletti, U. Fuhrman, and C. L. Walker Aberrant Expression of HMGA2 in Uterine Leiomyoma Associated with Loss of TSC2 Tumor Suppressor Gene Function Cancer Res., July 1, 2002; 62(13): 3766 - 3772. [Abstract] [Full Text] [PDF]

				J R Toro, Y O Shevchenko, J G Compton, and S J Bale Exclusion of PTEN, CTNNB1, and PTCH as candidate genes for Birt-Hogg-Dube syndrome J. Med. Genet., February 1, 2002; 39(2): e10 - 10. [Full Text] [PDF]

				C. L. Walker Role of Hormonal and Reproductive Factors in the Etiology and Treatment of Uterine Leiomyoma Recent Prog. Horm. Res., January 1, 2002; 57(1): 277 - 294. [Abstract] [Full Text] [PDF]

				C. L. Walker, K. Cesen-Cummings, C. Houle, D. Baird, J.C. Barrett, and B. Davis Protective effect of pregnancy for development of uterine leiomyoma Carcinogenesis, December 1, 2001; 22(12): 2049 - 2052. [Abstract] [Full Text] [PDF]

				J. C. Bischof, W. M. Fahssi, D. Smith, T. Nagel, and D. J. Swanlund A parametric study of freezing injury in ELT-3 uterine leiomyoma tumour cells Hum. Reprod., February 1, 2001; 16(2): 340 - 348. [Abstract] [Full Text] [PDF]

				K. D. Houston, D. S. Hunter, L. C. Hodges, and C. L. Walker Uterine Leiomyomas: Mechanisms of Tumorigenesis Toxicol Pathol, January 1, 2001; 29(1): 100 - 104. [Abstract] [PDF]

				S. D. Gamage, E. D. Bischoff, K. D. Burroughs, W. W. Lamph, M. M. Gottardis, C. L. Walker, and R. Fuchs-Young Efficacy of LGD1069 (Targretin), a Retinoid X Receptor-Selective Ligand, for Treatment of Uterine Leiomyoma J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 677 - 681. [Abstract] [Full Text]

				K. D. Burroughs, R. Fuchs-Young, B. Davis, and C. L. Walker Altered Hormonal Responsiveness of Proliferation and Apoptosis During Myometrial Maturation and the Development of Uterine Leiomyomas in the Rat Biol Reprod, November 1, 2000; 63(5): 1322 - 1330. [Abstract] [Full Text]

				C. L. Walker, K. D. Burroughs, B. Davis, K. Sowell, J. I. Everitt, and R. Fuchs-Young Preclinical Evidence for Therapeutic Efficacy of Selective Estrogen receptor Modulators for Uterine Leiomyoma Reproductive Sciences, July 1, 2000; 7(4): 249 - 256. [Abstract] [PDF]

				J. C. M. Tsibris, K. B. Porter, A. Jazayeri, G. Tzimas, H. Nau, H. Huang, K. Kuparadze, G. W. Porter, W. F. O'Brien, and W. N. Spellacy Human Uterine Leiomyomata Express Higher Levels of Peroxisome Proliferator-activated Receptor {{gamma}}, Retinoid X Receptor {{alpha}}, and all-trans Retinoic Acid Than Myometrium Cancer Res., November 1, 1999; 59(22): 5737 - 5744. [Abstract] [Full Text] [PDF]

				D. S. Hunter, L. C. Hodges, P. M. Vonier, R. Fuchs-Young, M. M. Gottardis, and C. L. Walker Estrogen Receptor Activation via Activation Function 2 Predicts Agonism of Xenoestrogens in Normal and Neoplastic Cells of the Uterine Myometrium Cancer Res., July 1, 1999; 59(13): 3090 - 3099. [Abstract] [Full Text] [PDF]

				B. J. Quade, A. P. Pinto, D. R. Howard, W. A. Peters III, and C. P. Crum Frequent Loss of Heterozygosity for Chromosome 10 in Uterine Leiomyosarcoma in Contrast to Leiomyoma Am. J. Pathol., March 1, 1999; 154(3): 945 - 950. [Abstract] [Full Text] [PDF]

				K. D. Burroughs, K. Kiguchi, S. R. Howe, R. Fuchs-Young, D. Trono, J. C. Barrett, and C. Walker Regulation of Apoptosis in Uterine Leiomyomata Endocrinology, July 1, 1997; 138(7): 3056 - 3064. [Abstract] [Full Text] [PDF]

				V. Launonen, O. Vierimaa, M. Kiuru, J. Isola, S. Roth, E. Pukkala, P. Sistonen, R. Herva, and L. A. Aaltonen Inherited susceptibility to uterine leiomyomas and renal cell cancer PNAS, March 13, 2001; 98(6): 3387 - 3392. [Abstract] [Full Text] [PDF]

				T. J. Jonasdottir, C. S. Mellersh, L. Moe, R. Heggebo, H. Gamlem, E. A. Ostrander, and F. Lingaas Genetic mapping of a naturally occurring hereditary renal cancer syndrome in dogs PNAS, April 11, 2000; 97(8): 4132 - 4137. [Abstract] [Full Text] [PDF]